Understanding SCCS opinions for children’s cosmetic safety is critical when preparing a CPSR for baby products in the EU. Unlike adult cosmetics, EU baby cosmetic regulations require specific exposure values, toxicology assessments, and strict ingredient limits.
It’s an entirely different standard. Its own science. Its own exposure values. It’s own SCCS opinions that every CPSR must directly address.
Whether you’re a safety assessor, brand owner, or formulator, this guide covers everything from basic EU regulation right through to expert-level CPSR requirements for baby and children’s products.
What Makes Children’s Cosmetic Safety EU Rules Different?
Children are not small adults. Their skin absorbs substances faster than adult skin. The stratum corneum is thinner in infants. Skin surface area relative to body weight is significantly higher. So more of an applied ingredient enters the bloodstream, even with less product used.
And on the elimination side, a baby’s liver and kidneys are still developing. They can’t break down and clear chemicals the way a healthy adult can.
This is the science behind the EU rules on children’s cosmetic safety. It’s not bureaucracy. Biology demands a higher standard.
If your cosmetic safety assessment of children, the EU treats a 4-month-old the same as a 60 kg adult, your MoS calculation is wrong. And your CPSR will not survive scrutiny.
What Is the SCCS, and Why Do Their Opinions Shape Your CPSR?
The Scientific Committee on Consumer Safety is the EU’s independent expert body. They evaluate cosmetic ingredient safety and publish scientific opinions based on toxicological evidence.
They also publish the SCCS Notes of Guidance, the methodology document that tells safety assessors exactly how to conduct their assessments.
Their opinions aren’t technically the law. But in practice, they define the scientific standard that EU cosmetic regulation operates against. When the European Commission identifies a potential risk from a cosmetic ingredient, it requests the SCCS to assess safety under foreseeable exposure conditions. Based on those SCCS opinions, the Commission can then amend the ingredient Annexes of Regulation (EC) 1223/2009.`
So when a safety assessor signs off on a CPSR, that conclusion must be grounded in current scientific evidence. SCCS opinions and the SCCS Notes are that evidence. Market surveillance authorities reference them directly.
Miss a relevant SCCS opinion or use an outdated Notes version, and your CPSR will have a gap that gets flagged.
EU Cosmetic Regulation Children’s Safety: The Legal Foundation
Regulation (EC) No 1223/2009 is the core law for all cosmetics sold in the EU. It covers adult products and baby cosmetics equally.
The regulation sets the basic rules, and the SCCS adds the detailed safety guidance.
EU Rules Baby Cosmetic Products: What the Annexes Cover
| Regulatory Element | What It Covers for Children |
| Annex II | Prohibited substances include child-specific bans |
| Annex III | Restricted substances, with some limits lower for children |
| SCCS Opinions | Ingredient-level safety conclusions, including children’s use |
| SCCS Notes of Guidance 12th revision | Methodology, including child-specific exposure scenarios |
The regulatory bar is actively moving, although no single sweeping formal amendment covering all children’s cosmetics has been adopted yet. Children’s product safety has become a clear and growing regulatory priority in the EU therefore CPSRs that passed two years ago may not pass today.
SCCS Notes: The Document Every Assessor Must Actually Know
The SCCS Notes of Guidance 12th revision, reference SCCS/1647/22, adopted 15 May 2023, is the current standard. It includes updated exposure data covering children specifically, across different cosmetic product categories and age groups.
Age Groups the SCCS Defines for Children’s Exposure
The SCCS doesn’t lump all children together. Age matters enormously here.
| Age Group | Category |
| 0 – 6 months | Newborn/young infant |
| 6 months – 2 years | Older infant/toddler |
| 2 – 6 years | Young child |
| 6 – 12 years | Older child |
Your CPSR for infant skincare products must use exposure values matching the exact age range on your product label.
A product labelled “for babies 0–6 months” needs newborn infant defaults. Using the wrong age group produces an inaccurate SED. And an inaccurate SED means an unreliable Margin of Safety.
SCCS Guidance: Children’s Exposure, The Numbers That Change Everything
The shift from adult to infant defaults is dramatic and this is where most CPSRs go wrong.
Children’s Exposure Limits SCCS EU:
| Parameter | Adult Default | Infant (0–6 months) |
| Body weight | 60 kg | 7.5 kg |
| Whole body leave-on lotion | 8.7 g | 3.15 g |
| Face leave-on product | 1.64 g | 0.45 g |
| Frequency of use | Variable | Often daily |
Here’s the part that surprises people every time. Even though less product is applied to an infant, the Systemic Exposure Dose ends up higher than for an adult. Because body weight is eight times lower, the lower body weight amplifies every exposure calculation.
That SED feeds directly into your Margin of Safety (MoS). A comfortable MoS of 200 for adults can fall below 100 for infants, using the same formula at the exact same concentration. Below 100 the product is not safe for that population. CPSR children’s exposure limits must use infant-specific defaults.
Baby Cosmetics: Why These Products Need a Different CPSR Approach
Baby cosmetics are a separate category designed for very sensitive skin and vulnerable users. They are used daily, often multiple times a day. This high frequency of use increases overall exposure and changes the risk profile.
Common Baby Products and What Makes Each One Complex
- Baby wash and shampoo are rinse-off products, but are used every day. Frequency matters even in rinse-off scenarios. Preservatives and fragrance allergens must still be assessed against children’s specific limits.
- Baby moisturisers and body lotions are leave-on products and sit in the highest exposure category. Every ingredient, fragrance, emollient, and preservative must be assessed using infant body weight and surface area.
- Nappy rash creams and barrier creams are applied to compromised, occluded skin. Absorption in the nappy area can be significantly higher than on normal intact skin. Your CPSR must explicitly acknowledge this; it changes the dermal absorption picture.
- Baby wipes are used multiple times daily, directly on the nappy area skin. Often, they contain preservatives, fragrance, and emollients. Cumulative daily exposure from wipes alone is substantial, and most brands underestimate it.
- Baby oils are high-volume leave-on products. Essential oil components and fragrance ingredients need careful assessment against children-specific limits. The volumes applied are larger than most people assume.
- Baby sun creams involve UV filters, and UV filter safety for children is a specific active area of SCCS review. Not all UV filters permitted in adult sunscreens are assessed as safe for young children. This is an area where SCCS opinions must be checked individually for each filter used.
The Cumulative Exposure Problem Nobody Mentions
Here’s the scenario nobody talks about enough.
A baby uses shampoo, body wash, lotion, nappy cream, and wipes, all in one routine. Each product contains the same preservative. Each one is “safe” at its individual concentration.
Together, the cumulative exposure picture is completely different.
The SCCS has specifically assessed certain preservatives and concluded they are not safe for children across multiple age groups when used in combination across product categories. Butylparaben is a direct example; the SCCS noted in its 2025 final opinion that combined use across product categories makes it unsafe for children from 0.5 years through to 10 years at maximum permitted concentrations.
Your CPSR for baby cosmetics should acknowledge cumulative exposure. You don’t always need a full formal calculation. But regulators increasingly expect evidence that you’ve considered it, not silence.
Citral SCCS Opinion Cosmetic Safety Assessment:
Citral is a fragrance ingredient, also known as sensitizer and is found in lemon myrtle, lemongrass, and countless “natural” baby products.
And the citral SCCS opinion cosmetic safety assessment is one of the most referenced and most frequently missed opinions in children’s product CPSRs.
The SCCS concluded clearly: concentration limits safe for adult products do not provide adequate safety margins for young children, especially in leave-on products.
Lower acceptable concentrations were set specifically for children’s products. Based on three things. Higher relative exposure due to lower body weight and higher skin surface area ratio. Sensitisation risk from immature immune systems—and cumulative daily exposure from multiple products.
If your baby product contains citral, from any source, including natural essential oils, your CPSR must directly reference the SCCS citral opinion. You must demonstrate that the concentration is safe for your specifically stated exact age group.
The “Natural” Trap That Catches Brands Out
Natural does not mean safe for babies. Regulators don’t give essential oils a free pass, and neither does the science.
Citrus oils, lavender, chamomile, and tea tree, popular ingredients in “natural” baby ranges, contain allergens and bioactive compounds that the SCCS has specifically reviewed for children’s use. Writing “this is a natural ingredient” in a CPSR is not a toxicological argument. It’s a marketing statement, and it will not hold up.
Toxicology for Children Cosmetic Products in CPSR:
Toxicology children cosmetic products assessment goes well beyond adjusting exposure numbers. These three areas make the real difference.
Dermal Absorption in Infant Skin
Infant skin is measurably more permeable than adult skin, especially in newborns. For most cosmetic ingredients, no specific infant dermal absorption value exists.
So you have two options. Apply a worst-case assumption. Or justify your chosen value explicitly and carefully in Part A.
What you cannot do is use adult dermal absorption data without acknowledging the gap. That approach likely underestimates real absorption in your target population. It’s exactly the kind of detail that market surveillance authorities look for and find.
Endocrine-Disrupting Concerns in Developing Children
Some ingredients raise specific concerns because children are in critical developmental windows. Low-level exposure to endocrine-disrupting substances can interfere with hormonal development in ways that simply don’t affect adults.
When assessing preservatives, UV filters, or certain fragrance compounds in children’s products, your CPSR must address endocrine disruption potential explicitly, even when data is limited. “No data found” is no longer an acceptable standalone conclusion in a children’s product CPSR.
Children’s Skin Sensitivity Cosmetics EU:
Early-life exposure to sensitisers can create long-term allergic responses that last a lifetime. Children’s skin sensitivity to cosmetics in the EU is a growing area of SCCS focus, and fragrance allergens from natural sources carry particular concern.
Hexyl salicylate is a direct example. The SCCS opinion concluded that it is prohibited in cosmetics for children under 3 unless present as a technically unavoidable trace impurity. That’s not a limit. That’s a ban.
Every potential sensitiser in your formulation must be identified. Each one assessed against children-specific limits, not adult limits.
CPSR Requirements for Children’s Products, Part A and Part B
A cosmetic product safety report for kids has two parts. Both need specific content that a standard adult CPSR doesn’t require.
CPSR for Infant Skincare Products: Part A Must Include
| Part A Element | What’s Required for Children’s Products |
| Target age group | Defined precisely, must match the label claim exactly |
| Exposure scenario | Child-specific defaults from current SCCS Notes |
| Toxicological profiles | Addressing children’s physiology where relevant |
| SCCS opinions | All relevant ones cited AND applied, not just listed |
| SED calculation inputs | Child-appropriate body weight and exposure values |
| Dermal absorption | Justified for infant skin, not assumed from adult data |
If any ingredient has a children-specific SCCS opinion, it must be identified, its conclusions applied to your actual formulation concentration, and the reasoning documented. Listing the opinion without applying it is not enough.
Part B: The Safety Assessor’s Sign-Off for Children’s Products
Part B is where the qualified assessor draws their conclusion. For children’s products, it must explicitly confirm:
- A child-specific exposure scenario was used throughout
- MoS calculations used infant or child body weight, not adult defaults
- Sensitisation concerns relevant to the target age group were addressed
- Cumulative exposure was considered
- The product is safe for the specifically stated age group
That last point matters more than people realise. “Safe for use as directed” is not enough. The conclusion must name the age group, and it must be backed by a clear calculation trail in Part A.
Safety Limits for Baby Skincare EU: Most Common CPSR Failures
Here’s what goes wrong most often.
| Common Failure | Why It Fails |
| Adult body weight (60 kg) used for infant product | Underestimates SED by up to 8 times |
| Citral SCCS opinion not referenced or applied | Non-compliance with the current scientific standard |
| No specific age group is defined in CPSR | Assessor cannot confirm safety for the intended user |
| “Natural = safe” is used as a toxicological argument | Invalid, not accepted by regulators |
| Outdated SCCS Notes version referenced | Assessment may not meet the current standard |
| Cumulative exposure is not mentioned | Incomplete risk assessment, regulators notice |
| Adult dermal absorption is used without justification | Likely underestimates infant absorption |
| Nappy area application not flagged | Occluded, compromised skin needs specific acknowledgement |
If any of these apply to a CPSR you’re working on, revisit it before the product reaches the EU market. Or before an inspection finds it first.
SCCS Risk Assessment Children Cosmetics:
Here’s a clean, practical workflow for building a solid CPSR for infant skincare products.
Step 1: Define the population precisely. Before any calculation, nail down exactly who this product is for. “Babies” is not precise enough. “0–12 months” is. The age range on the label determines every exposure default you’ll use.
Step 2: Pull the current SCCS Notes version. SCCS/1647/22 is the current 12th revision. Reference the version number in Part A. An older version, even used with good intentions, produces a non-conforming CPSR.
Step 3: Screen every ingredient for SCCS opinions, especially fragrances, preservatives, and UV filters. If a children-specific opinion exists, apply it. If the opinion sets a lower limit for children than your formula concentration, that’s a formulation problem. It cannot be resolved in the CPSR text.
Step 4: Run SED and MoS with infant-specific values, then address sensitisation and cumulative exposure. Document every assumption. Identify all sensitisers. Acknowledge cumulative daily product use. Show your reasoning; regulators want to see the thinking, not just the conclusion.
CPSR Checklist for Children’s and Baby Cosmetics
Run through this before any sign-off on a children’s product CPSR.
| Checklist Item | Done? |
| Age group defined, child-specific exposure values applied | ✓ |
| Infant body weight defaults used, not adult | ✓ |
| All relevant SCCS opinions were reviewed and applied to the formulation. | ✓ |
| Citral and all sensitisers assessed against children’s limits | ✓ |
| Current SCCS Notes version (SCCS/1647/22) referenced in Part A | ✓ |
| Cumulative exposure acknowledged in the assessment | ✓ |
| Part B conclusion names the specific age group. | ✓ |
| Dermal absorption assumption justified for infant skin | ✓ |
| Nappy area application flagged where relevant | ✓ |
| Assessor qualifications confirmed per Annex I | ✓ |
FAQs
What is SCCS in cosmetic safety?
The Scientific Committee on Consumer Safety (SCCS) is the EU body that evaluates cosmetic ingredient safety. Its opinions guide CPSR requirements, especially for children’s cosmetics, where stricter exposure limits and toxicological assessments apply.
Why are children’s cosmetics regulated differently?
Children’s cosmetics are regulated differently because infant skin absorbs substances more easily, and their bodies cannot process chemicals like adults. This requires stricter CPSR assessments and SCCS-based exposure limits.
What is a CPSR, and why does it matter for baby cosmetics?
A CPSR, Cosmetic Product Safety Report, is a mandatory document before any cosmetic can be sold in the EU. For baby cosmetics, it must use child-specific exposure values and address all relevant SCCS opinions for children’s use. Without a compliant CPSR, your product cannot legally reach the EU market.
Do SCCS opinions apply legally to my CPSR?
Not as law directly. But they define the scientific standard that regulators use to judge whether a CPSR is adequate. If a relevant SCCS opinion exists and your CPSR ignores it, your assessment is considered scientifically inadequate. In practice, applying SCCS opinions is not optional.
Can I use adult exposure defaults for a baby product if less product is applied?
No, and this is one of the most common mistakes. Even with smaller amounts applied, infant body weight is so much lower that the SED ends up higher than for adults. The SCCS Notes provide specific infant defaults. Those are the values your CPSR must use.
Are natural ingredients automatically safe in baby cosmetics?
No. Many natural ingredients, citrus oils, lavender, and chamomile, contain fragrance allergens that the SCCS has specifically reviewed for children. The citral SCCS opinion is the clearest example. “Natural” is not a safety argument in a CPSR. Every ingredient needs a proper assessment regardless of origin.
Final Verdict
Here’s the honest bottom line: writing a CPSR for baby or children’s cosmetics is more demanding than for adult products. It requires correct exposure values, current SCCS opinions, and accurate toxicological reasoning, all properly applied, not just referenced.
The SCCS review process for children’s ingredients is tightening, with new opinions regularly published. In 2025, SCCS strengthened limits on methyl salicylate to 0.02% for children aged 0–3, and confirmed that butylparaben is unsafe in multiple use scenarios.
Think of it like this:
Adult CPSR = standard safety check
Baby CPSR = high-risk, strict safety check
These updates show baby skincare safety in the EU is tightening, not loosening. For brands, formulations must follow current SCCS limits from day one, not be fixed later during CPSR review. For safety assessors, staying current with SCCS publications, Notes revisions, and children’s exposure defaults is essential.
Finally, CPSR for children’s cosmetics is not a box-ticking exercise but a protection framework for vulnerable users. And that is why accuracy, consistency, and responsibility always truly matter most.
